The caspase-1 inhibitor VX765 inhibited caspase-1, suppressed the expression of GSDMD and its cleavage form GSDMD-NT, reduced the pyroptosis and sepsis-induced impairment of the blood–brain barrier and structural damage in the brain. Here, CASP1 is linked to Sepsis.